Keith R. Edwards

Medicine · Health Sciences

42h-index7.1kcitations164works9.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(46), Peatlands and Wetlands Ecology(26), Coastal wetland ecosystem dynamics(20), Polyomavirus and related diseases(16), Botany and Plant Ecology Studies(14)

Publications157 total

Labile heparin response in a pre-operative cardiac surgery patient: Unmasking predisposition for post-operative coagulopathy
Blood·2025Open Access
Wetland Plant Zonation and Succession
2025
Changing environmental conditions impact the phenotypic plasticity of Carex acuta and Glyceria maxima, two common wet grassland species
Frontiers in Plant Science·2025Open Access
Multiple environmental factors interact to affect wet grassland ecosystem functions
Ecological Engineering·2025· 4 cited
Correction: Environmental Efects on Assimilated Carbon Quantity and Quality in Two Diferent Wet Grassland Plants
Wetlands·2024Open Access
Environmental Effects on Assimilated Carbon Quantity and Quality in Two Different Wet Grassland Plants
Wetlands·2024· 2 cited
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis
JAMA Neurology·2024· 72 citedOpen Access
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet
Neurology·2023· 97 citedOpen Access
Multiple environmental factors, but not nutrient addition, directly affect wet grassland soil microbial community structure: a mesocosm study
FEMS Microbiology Ecology·2023· 11 citedOpen Access
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
Proceedings of the National Academy of Sciences·2023· 50 citedOpen Access
Peak-season and off-season distribution of mineral nutrients in littoral vegetation of an ancient shallow reservoir
Hydrobiologia·2022· 2 cited
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease
JAMA Neurology·2022· 175 citedOpen Access
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections
Vaccines·2022· 23 citedOpen Access
Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemic
Multiple Sclerosis and Related Disorders·2022· 14 citedOpen Access
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data
Multiple Sclerosis and Related Disorders·2021· 30 citedOpen Access
Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age
Multiple Sclerosis and Related Disorders·2021· 29 cited
The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide
Multiple Sclerosis Journal - Experimental Translational and Clinical·2021· 5 citedOpen Access
Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma
Brain·2021· 82 citedOpen Access
COVID-19 mRNA vaccination leading to CNS inflammation: a case series
Journal of Neurology·2021· 130 citedOpen Access
Riparian populations of minnesota reed canarygrass (Phalaris arundinacea) are most likely native, based on SNPs (DArTseqLD)
Wetlands Ecology and Management·2021· 12 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Hana Šantrůčková(6), Eva Kaštovská(5), Tomáš Picek(4), Andrew Goodman(3), Jan Ilkowski(3), Mark Brody(3), Concetta Forchetti(3), Lawrence S. Honig(3), Peter A. Calabresi(3), Gabriel Pardo(3), Ralf Gold(3), Fredrik Piehl(3), Anne H. Cross(3), C. Edward Proffitt(3), Stephen Salloway(3), Erin E. Longbrake(3), Patricia K. Coyle(3), Lauren Krupp(2), Edmond Teng(2), Flávia Brunstein(2)